This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Walter Louis Verstappen: Innovator in Pharmaceutical Chemistry
Introduction
Walter Louis Verstappen, an accomplished inventor from Kontich, Belgium, has made significant contributions to the field of pharmaceutical chemistry. With two patents to his name, he has showcased his expertise in developing innovative processes that advance the preparation of enantiomerically pure compounds.
Latest Patents
His latest patents highlight a sophisticated method for preparing enantiomerically pure 6-{4-chlorophenyl}(1H-1,2,4-triazol-1-yl)methyl!-1-methyl-1H-benzotriazole. This process involves the resolution of (±)-6-{(4-chlorophenyl)-hydrazinomethyl}-1-methyl-1H-benzotriazole, converting the appropriate enantiomerically pure hydrazine intermediate into (+)-6-{(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl!-1-methyl-1H-benzotriazole. Such advancements are crucial for the development of effective pharmaceutical agents.
Career Highlights
Walter is currently associated with Janssen Pharmaceutica NV, a renowned name in the pharmaceutical industry, where he continues to apply his skills and knowledge to innovate drug formulations. His commitment to research and development has contributed to creating solutions that address contemporary health challenges.
Collaborations
Throughout his career, Walter has had the opportunity to collaborate with notable colleagues such as Albert Louis Willemsens and Alex Herman Copmans. These collaborations have further enriched his work and allowed for a more profound impact in the field of pharmaceutical chemistry.
Conclusion
Walter Louis Verstappen exemplifies the spirit of innovation in the realm of pharmaceutical research. Through his patents and collaborative efforts, he continues to push the boundaries of what is possible in creating effective and enantiomerically pure compounds essential for the advancement of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
